Viewing Study NCT06354218


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:04 AM
Study NCT ID: NCT06354218
Status: RECRUITING
Last Update Posted: 2024-04-09
First Post: 2024-04-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module